Amedisys - 30 Year Stock Split History | AMED

Stock split history for Amedisys since 1994. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Amedisys Annual Stock Splits
Amedisys Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $2.978B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.465B 9.96
Quest Diagnostics (DGX) United States $15.044B 15.55
DaVita (DVA) United States $11.644B 15.84
Chemed (CHE) United States $8.667B 26.91
Encompass Health (EHC) United States $8.285B 21.32
Elanco Animal Health (ELAN) United States $6.443B 14.65
Option Care Health (OPCH) United States $5.091B 19.27
RadNet (RDNT) United States $3.345B 97.70
LifeStance Health (LFST) United States $2.355B 0.00
Astrana Health (ASTH) United States $2.048B 25.57
U.S Physical Therapy (USPH) United States $1.513B 39.21
Addus HomeCare (ADUS) United States $1.501B 22.81
Pennant (PNTG) United States $0.610B 35.63
Aveanna Healthcare Holdings (AVAH) United States $0.423B 0.00
Atai Life Sciences (ATAI) Germany $0.308B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.018B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
Ontrak (OTRK) United States $0.009B 0.00
IMAC Holdings (BACK) United States $0.006B 0.00